Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Account Payables

Amounts the company owes suppliers for goods and services received.

No reported Account Payables figures are available to summarize.

Account Payables history

Currency unavailable · from the balance sheet

No Account Payables data reported for this period type.

Account Payables vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Account Payables for ODTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ACRSAclaris Therapeutics, Inc.Mar 2026$14.73M USD+131.8%+8.3%7.4%
ORKAOruka Therapeutics, Inc.Sep 2026$14.38M USD+551.1%+131.7%1.2%
ALMSAlumis Inc. Common StockJun 2026$12.8M USD-14.6%+80.4%2.3%
IMUXImmunic, Inc.Mar 2026$10.51M USD+90.9%+33.3%5.5%
SYRESpyre Therapeutics, Inc.Sep 2026$9.47M USD+26.9%+136.0%0.9%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€7.58M EUR——4.6%
ANABAnaptysBio, Inc.Mar 2026$7.52M USD+22.8%+11.6%2.3%
PTGXProtagonist Therapeutics, Inc.Jun 2026$3.46M USD+6.5%+13.6%0.4%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —+26.9%+33.3%2.3%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.